| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Mediplantex National Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫26,800.00 |
| 52 Week High | ₫30,800.00 |
| 52 Week Low | ₫21,100.00 |
| Beta | 0.064 |
| 11 Month Change | -3.60% |
| 3 Month Change | 7.20% |
| 1 Year Change | 16.52% |
| 33 Year Change | -31.81% |
| 5 Year Change | n/a |
| Change since IPO | -45.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| MED | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | -2.9% |
| 1Y | 16.5% | 11.6% | 2.1% |
Return vs Industry: MED exceeded the VN Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: MED exceeded the VN Market which returned 2.1% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.9% |
| 10% least volatile stocks in VN Market | 2.8% |
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | n/a | n/a | www.mediplantex.com |
Mediplantex National Pharmaceutical Joint Stock Company operates as a pharmaceutical company in Vietnam. It provides pharmaceutical products in various categories, including drugs from herbals, analgesics - corticosteroid - anti-inflammatory, antibiotics, anti-malarial and demostasis drugs, gout-diabetes drugs, allergies and osteoarthritis drugs, and acid amin-vitamins and minerals, as well as cerebral circulation, heart, and lung drugs. The company also offers medicinal plant products; and extracting and semi synthetic materials, such as essential oils.
Mediplantex National Pharmaceutical Joint Stock Company Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | ₫302.80b |
| Earnings (TTM) | ₫16.28b |
| Revenue (TTM) | ₫462.65b |
20.4x
P/E Ratio0.7x
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | ₫462.65b |
| Cost of Revenue | ₫368.23b |
| Gross Profit | ₫94.42b |
| Other Expenses | ₫78.14b |
| Earnings | ₫16.28b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.31k |
| Gross Margin | 20.41% |
| Net Profit Margin | 3.52% |
| Debt/Equity Ratio | 25.7% |
How did MED perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield43%
Payout RatioDoes MED pay a reliable dividends?
See MED dividend history and benchmarks| Mediplantex National Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Aug 01 2024 |
| Dividend Pay Date | Aug 22 2024 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 27 days |
Does MED pay a reliable dividends?
See MED dividend history and benchmarks